Mitochondrial dysfunction
Mitochondria, the cell's power plants, make less energy as they age and leak DNA that the body mistakes for an infection, one of the leading suspected drivers of age-related inflammation. Exercise has by far the best human evidence for improving them. Fasting, heat and cold are thought to work the same way but are far less tested, and no supplement has shown a benefit on any hard outcome.
Train regularly, in whatever mix of easy aerobic work, intervals and strength training adds up to a steady weekly training load, built up gradually rather than piled on. Protect your sleep, which early evidence suggests matters too. Don't take high-dose vitamin C and E supplements around training, and treat the mitochondrial supplements as unproven.
What mitochondria do, and how they wear out
Mitochondria are tiny compartments inside nearly every cell that burn fuel and oxygen to make adenosine triphosphate (ATP), the molecule that powers almost everything a cell does. They also buffer calcium, decide when a damaged cell should die, and produce reactive oxygen species (ROS), unstable oxygen-containing by-products that damage whatever they touch.[1] Their decline is the seventh of the twelve hallmarks of aging, and one of the most connected: it both feeds and is fed by genomic instability, senescence and inflammation.
That mitochondria decay with age is settled. They carry their own small loop of DNA, a relic of their origin as free-living bacteria, and it is unusually exposed: packed in small protein bundles rather than wound around histones as the nucleus's DNA is, sitting right next to the energy machinery, and with a more limited repair toolkit. It picks up mutations and deletions faster (one estimate puts the rate up to 15 times higher), and these have been mapped in aging human brain, heart, colon and muscle.[2] Free radicals are the usual suspect, but in one ultra-sensitive sequencing study of human brain tissue, point mutations rose about five-fold over 80 years while the type oxidative damage leaves did not; most seem to come from copying errors and spontaneous chemical decay.[3]
The cell's defence is constant rebuilding, on a timescale of days to weeks depending on the tissue: in mice, the average mitochondrial protein has a half-life of about 4 days in the liver and about 17 days in the heart.[4] The cell builds new mitochondria (biogenesis, driven by a master switch called PGC-1α), digests worn-out ones (mitophagy), and splits and merges them to quarantine damage. With age the switch weakens, clearance slows and damaged mitochondria pile up, making less ATP and leaking more ROS, though most of this detail comes from cell and animal studies.[5]
How a local energy problem becomes body-wide inflammation
The best-mapped route from failing mitochondria to whole-body aging runs through the same misplaced-DNA alarm that connects genomic instability to aging. Because mitochondrial DNA still resembles bacterial DNA, the cell treats it as a threat if it ends up in the wrong place. When a damaged mitochondrion ruptures, its DNA spills into the cell, where a sensor called cGAS-STING, the cell's burglar alarm for misplaced DNA, mistakes it for a virus and switches on an inflammatory programme.[6]
A brief burst is useful housekeeping. Chronic activation that never resolves is the problem: it turns accumulated damage into the persistent low-grade inflammation of inflammaging. In senescent cells, sustained cGAS-STING signalling drives the inflammatory secretions that damage neighbouring tissue.[7]
The mechanism is well established in cells and mice; how much of human inflammaging runs through it is not known. In people the link is observational: in a study of 672 older adults, mitochondrial DNA circulating in the blood tracked inflammatory markers, but it did not predict death once inflammation was taken into account.[8]
Muscle and brain: strong associations, no proof of cause
Mitochondrial decline shows up first where energy demand is highest, in skeletal muscle and the brain, but every human result here is observational. Failing mitochondria are a likely contributor to sarcopenia (age-related muscle loss) and frailty. Muscle samples from 119 older men in Singapore, the UK and Jamaica showed fewer and weaker mitochondria in those with sarcopenia than in men of the same age without it.[9] In the largest study to measure this directly, about 900 people aged 70 and over had thigh-muscle samples tested. Those with weaker muscle mitochondria were more likely to be frail and took longer to walk 400 metres, though the walking link ran largely through leg power and the energy cost of walking.[10][11]
Muscle mitochondria also track the brain. In a long-running study of aging adults in Baltimore, thigh-muscle mitochondrial function, measured by magnetic-resonance scanning, predicted what happened next. People whose muscle mitochondria scored one standard deviation better than average went on to develop mild cognitive impairment or dementia at roughly half the rate (a 52% lower hazard), and had about 59% lower odds of a positive amyloid brain scan.[12] People with better muscle mitochondria differ in many other ways, and no trial has tested whether improving them changes the brain outcome. A smaller comparison found muscle differences in early mild cognitive impairment too, but in only 50 people, and entangled with use of the Alzheimer's drug donepezil.[13]
A related energy failure may underlie post-infectious chronic fatigue syndrome, though the evidence is early. One US National Institutes of Health study found raised levels of a stress-induced protein, WASF3, in muscle samples from 14 people with myalgic encephalomyelitis/chronic fatigue syndrome compared with 10 healthy volunteers. In one patient's cells and in mice, the same protein jammed the assembly of the energy machinery and cut energy output.[14] The authors suggest long COVID might work the same way, but they studied no long-COVID patients, and the finding has not yet been independently confirmed.
A little stress is the point
The old free-radical theory treated all mitochondrial stress as damage to minimise. The modern picture is mitohormesis: high, chronic stress is destructive, but a brief, controlled dose makes the cell overcompensate, clearing damaged mitochondria, building new ones and ending up more resilient.[15] The principle is well established in cells and animals; whether a given change helps or harms depends on the dose,[16] and in people the dose boundaries are not mapped.
This is why high-dose antioxidant supplements don't slow aging, and why taken around training they can blunt part of what the training does. The burst of ROS that exercise produces is part of the signal that tells the cell to build more mitochondria. In small trials of young adults, about 1 g of vitamin C a day together with vitamin E, taken during training, blunted the rise in muscle mitochondrial markers and, in one trial, cancelled the improvement in insulin sensitivity.[17][18] Measured fitness mostly came out the same; in the largest trial (54 people, 11 weeks) it rose by about 8% with or without the vitamins,[19] and a 2025 sprint-training trial again blunted the muscle response but not the performance gain.[20] In one trial in older men, though, the vitamins shrank the gain in muscle mass.[21] They bring no training benefit, so there is no reason to take them. Antioxidants in food, at food doses, are a different matter.
Exercise: the lever with the best human evidence
Exercise reliably and measurably improves mitochondrial function in people, and both easy and hard training work. Steady, conversational-pace zone 2 training and harder intervals build more mitochondria by about the same amount: across hundreds of human training studies, mitochondrial content rose by roughly a quarter either way. What predicts the gain is total training load, how much you train times how hard, so intervals get there in less time, while easy work is the intensity most people can do a lot of.[22]
The response does not fade with age. In the same analysis the gains were not influenced by age, sex or disease, and the least fit gained the most. Strength training also improves mitochondrial function in older adults, alongside its role against muscle loss, though whether it also builds more mitochondria in them, as it does in the young, is inconsistent across studies.[23]
The dose still matters. In a four-week experiment in healthy volunteers, steadily piling on more training led, after the heaviest week, to a sharp drop in mitochondrial function and worse blood-sugar control.[24] Mixing mostly easy sessions with a smaller dose of hard ones is a sustainable way to build training load, though that mix has not been shown to be a stronger stimulus in itself. The gains show up as a higher VO₂ max, one of the strongest predictors of mortality. None of this has been tested against lifespan.
Fasting, heat, cold and sleep: plausible, thinly tested
The other hormetic levers have much weaker human evidence: largely animal work for cold and for fasting's effect on mitochondrial cleanup, a few small, short human trials for heat and sleep.
Fasting. In animals, low fuel switches on mitophagy, and fasting also dampens the growth pathway mTOR (the mechanistic target of rapamycin).[25] In people it is thin: in a six-month trial in 36 overweight adults, cutting calories by a quarter raised muscle mitochondrial DNA but not mitochondrial enzyme activity,[26] and in healthy men an 8-hour fast did not switch on the cleanup markers in muscle.[27] Nor does meal timing add a metabolic edge of its own: trials that match calories find time-restricted eating and fasting do about as well as ordinary calorie cutting, not better.[28][29] The animal machinery is described under deregulated nutrient sensing.
Heat. Heat triggers the heat-shock response, which makes protective proteins. In small human trials, two hours a day of deep heating of the thigh muscle raised those proteins and the muscle's mitochondrial capacity,[30] and during 10 days of leg immobilisation it cut the loss of mitochondrial function from about 27% to about 8%.[31] That was targeted muscle heating, not sauna. Whether ordinary sauna sessions do the same is untested, and whether this explains sauna's observational link with lower mortality is unproven.
Cold. In mice, cold exposure raises the activity of mitochondria-building genes in muscle.[32] Whether brief cold plunges do anything similar in humans is unsettled, and most of the human metabolic evidence comes from prolonged mild-cold air exposure rather than ice baths.
Sleep. Mitochondrial energy output and antioxidant defences run on the 24-hour clock,[33] and in flies and rodents sleep loss disturbs mitochondrial gene expression and raises oxidative stress in the brain.[34] The human evidence is small but direct. In a trial of 24 healthy young men, five nights limited to 4 hours in bed cut muscle mitochondrial function and worsened blood-sugar handling; in the group that also did three high-intensity interval sessions that week, neither happened.[35] Animal studies suggest mitochondria make their own melatonin as a local antioxidant, but this has not been shown in living human tissue and seems not to depend on the night-time melatonin the pineal gland releases,[36] so the case for consistent, dark-aligned sleep rests on the sleep-loss evidence, not on melatonin.
Supplements and drugs: small surrogate wins, no hard outcomes
None of these has shown a benefit on disease or survival. The few randomised trials that met their main goal were small, short and measured stand-in markers; the larger muscle and performance trials mostly missed theirs. The wider field is compared on geroprotectors.
Urolithin A has the most human data of the group, and it is equivocal. It is made by gut bacteria from pomegranate and berry compounds, though roughly 1 in 10 people make none at all,[37][38] and it stimulates mitophagy. The largest trial, in 88 overweight middle-aged adults over four months, found hamstring strength rose about 10–12% against a fall of about 10% on placebo, but it missed its primary endpoint of peak power and was sponsored by the maker, with all but one author its employees, board members or advisers.[39] A trial in 66 adults aged 65–90 missed both of its primary endpoints.[40] Two later four-week trials split: a maker-funded one shifted immune cells toward a younger-looking profile,[41] while an independent one in adults with obesity found no improvement in artery function.[42] There is no established benefit in older people.
NAD⁺ precursors, nicotinamide mononucleotide and nicotinamide riboside, reliably raise blood levels of NAD⁺, a coenzyme essential to energy production that declines with age. The functional payoff is where the evidence is weakest. A randomised trial gave 32 adults aged 55–80 nicotinamide riboside with pterostilbene around an induced muscle injury and found no improvement in muscle stem-cell recruitment or recovery.[43] A 10-week trial in 25 postmenopausal women with overweight or obesity and prediabetes found that 250 mg a day of nicotinamide mononucleotide improved how well their muscle responded to insulin, its main goal, but blood sugar, body composition, blood pressure and the muscle's mitochondrial capacity did not change.[44]
MitoQ, an antioxidant built to collect inside mitochondria, raised a standard measure of artery function by about 40% against placebo in a 6-week crossover trial of 20 healthy adults aged 60–79 whose artery function was already below normal.[45] It was small and short, it measured a stand-in rather than heart attacks or strokes, and one of the compound's developers was a co-author.
Coenzyme Q10 is part of the energy chain itself and can help in rare inherited CoQ10 deficiency. For statin muscle aches the evidence is contested, with at most a slight benefit in pooled small trials,[46] and for healthy adults the longevity case is thin.
Rapamycin blocks mTOR and is among the most studied candidate geroprotectors. Researchers hope low, intermittent doses can keep its benefits while avoiding its metabolic and immune side effects, but the right dose and schedule in people are unknown.[47] Its placebo-controlled trials in healthy adults have so far shown no benefit. One missed its main goal,[48] and in a 2026 trial in 40 sedentary people aged 65–85, weekly rapamycin did not improve the gains from an exercise programme; if anything the placebo group did slightly better, with fewer side effects.[49] It is firmly investigational.
Elamipretide, a drug that binds a fat molecule in the inner mitochondrial membrane, received US accelerated approval in 2025 to improve muscle strength in Barth syndrome, an ultra-rare inherited disease.[50] It says nothing about normal aging.
Why striking mouse results need a discount
Labs keep mice at around 22 °C, well below their comfort zone of about 30 °C, so they live under constant mild cold stress: a mouse at 22 °C spends more energy making heat than its whole body uses at rest,[51] pushing its total energy use to roughly three times its resting rate.[52] Cold is itself a mitochondrial stimulus, so standard housing distorts exactly the system this page is about.
This is a reason to discount specific metabolic readouts, not to throw out mouse lifespan findings. In one long-lived mutant strain, mice lacking the growth-hormone receptor, housing at 30 °C from weaning cut heat production by about a quarter but did not shorten their lives; females even lived 14% longer.[53]
Further reading
- Wei P, et al. Mitochondrial dysfunction and aging: multidimensional mechanisms and therapeutic strategies. Biogerontology 2025.[54]
- Gorgori-Gonzalez A, et al. Leveraging mitochondrial stress to improve healthy aging. Sports Med Health Sci 2026.[55]
- Ding W, et al. Mitochondrial DNA leakage triggers inflammation in age-related cardiovascular diseases. Front Cell Dev Biol 2024.[56]
- Tian Q, et al. Skeletal muscle mitochondrial function predicts cognitive impairment and is associated with biomarkers of Alzheimer's disease and neurodegeneration. Alzheimers Dement 2023 — Baltimore Longitudinal Study of Aging.[57]
- Mølmen KS, et al. Effects of Exercise Training on Mitochondrial and Capillary Growth in Human Skeletal Muscle: A Systematic Review and Meta-Regression. Sports Med 2025.[58]
- Paulsen G, et al. Vitamin C and E supplementation hampers cellular adaptation to endurance training in humans: a double-blind, randomised, controlled trial. J Physiol 2014.[59]
- Flockhart M, et al. Excessive exercise training causes mitochondrial functional impairment and decreases glucose tolerance in healthy volunteers. Cell Metab 2021.[60]
- Saner NJ, et al. Exercise mitigates sleep-loss-induced changes in glucose tolerance, mitochondrial function, sarcoplasmic protein synthesis, and diurnal rhythms. Mol Metab 2021.[61]
- Singh A, et al. Urolithin A improves muscle strength, exercise performance, and biomarkers of mitochondrial health in a randomized trial in middle-aged adults. Cell Rep Med 2022 — missed its primary endpoint; 8 of 9 authors tied to the maker.[62]
- Liu S, et al. Effect of Urolithin A Supplementation on Muscle Endurance and Mitochondrial Health in Older Adults: A Randomized Clinical Trial. JAMA Netw Open 2022 — missed both primary endpoints.[63]
- Yoshino M, et al. Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science 2021.[64]
- James CM, et al. How murine models of human disease and immunity are influenced by housing temperature and mild thermal stress. Temperature (Austin) 2023.[65]